Zhuhai Trinomab Pharmaceutical Co., Ltd.

¥22.90As of Sun 8 Nov 2026, 12:00 UTC
SSE:688806Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap ¥10.55B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥27
20.04%
(76.14%)
Hold 2|12|1|6|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.25
0.26
0.28
0.29
7.11%
9.79%
11.98%
19.36%
Revenue¥M
686.3
721.1
740.5
745.7
5.56%
9.89%
14.62%
9.12%
Peers (US$1.581B)
Cap (US$)
PE
1.576B
42.18x
Capital
TTM
5Y
10Y
Leveragex
3.521
—
(0.013)
EBIT/Intx
0.667
2.497
2.047
Own earn%
(74.66)
(57.87)
(57.38)
Sh yield%
49.51
21.31
22.39
Owners
Insiders/Inst%
6.86
83.38
Short interest%
4.80
SBC / revenue%
4.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
3–11
$1 testx
—
Incr. ROIC%
1